postbiotics

Industry, Oncology

Microbio’s MS-20 shows breakthrough potential in enhancing Keytruda for advanced lung cancer

The study revealed that MS-20 dramatically improved treatment outcomes, tripling the objective response rate (ORR) to 75% when combined with Keytruda.

Video, Events

The ‘all biotic’ revolution: what is next and what do all these terms really mean?

George Paraskevakos, Executive Director at International Probiotics Association, discusses the future of the microbiome space.

Events

IPC 2023 and the postbiotics session: the gathering of the different parties

The highlights of the Postbiotics Discussion Panel that took place in Bratislava during IPC 2023.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

MicrobiomePost

MicrobiomeHUB

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.